We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $256M
1-Year Est. Return 25.01%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24.6B
AUM Growth
-$539M
Cap. Flow
-$2.74B
Cap. Flow %
-11.15%
Top 10 Hldgs %
16.61%
Holding
1,387
New
97
Increased
426
Reduced
465
Closed
225

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$66.4M
2
MSFT icon
Microsoft
MSFT
+$52.8M
3
MA icon
Mastercard
MA
+$39.5M
4
LIN icon
Linde
LIN
+$28.7M
5
RACE icon
Ferrari
RACE
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 25.11%
2 Healthcare 16.99%
3 Financials 12.25%
4 Consumer Discretionary 11.39%
5 Industrials 8.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
51
Bank of America
BAC
$434B
$99M 0.4%
2,811,443
-174,263
-6% -$5.63M
NOW icon
52
ServiceNow
NOW
$121B
$98.3M 0.4%
1,740,895
-87,575
-5% -$4.61M
ECL icon
53
Ecolab
ECL
$79.4B
$95.3M 0.39%
493,839
+6,251
+1% +$1.19M
XOM icon
54
ExxonMobil
XOM
$649B
$92.8M 0.38%
1,330,272
-468,344
-26% -$32.4M
GILD icon
55
Gilead Sciences
GILD
$167B
$92.7M 0.38%
1,426,180
-200,196
-12% -$13M
TRMB icon
56
Trimble
TRMB
$13.8B
$92.6M 0.38%
2,221,139
-367,437
-14% -$14.6M
CRM icon
57
Salesforce
CRM
$155B
$92.2M 0.38%
567,145
-10,271
-2% -$1.61M
TGT icon
58
Target
TGT
$66.9B
$90.3M 0.37%
704,662
-111,776
-14% -$13.1M
SLAB icon
59
Silicon Laboratories
SLAB
$7.17B
$88.9M 0.36%
766,374
-56,406
-7% -$6.19M
NKE icon
60
Nike
NKE
$64.7B
$88.2M 0.36%
870,370
+13,044
+2% +$1.23M
ZTS icon
61
Zoetis
ZTS
$32.6B
$88.2M 0.36%
666,115
+81,077
+14% +$10.1M
BMY icon
62
Bristol-Myers Squibb
BMY
$130B
$87.9M 0.36%
1,370,001
-82,493
-6% -$4.72M
BKNG icon
63
Booking.com
BKNG
$158B
$87.4M 0.36%
1,063,900
-135,850
-11% -$10.7M
VRTX icon
64
Vertex Pharmaceuticals
VRTX
$124B
$87.4M 0.36%
399,106
+108,147
+37% +$21.9M
DHR icon
65
Danaher
DHR
$140B
$84.7M 0.34%
622,551
+20,483
+3% +$2.59M
LLY icon
66
Eli Lilly
LLY
$1.09T
$83.8M 0.34%
637,804
+7,106
+1% +$824K
RTN
67
DELISTED
Raytheon Company
RTN
$83.5M 0.34%
380,168
-30,900
-8% -$6.53M
NXPI icon
68
NXP Semiconductors
NXPI
$63.3B
$83.5M 0.34%
655,880
+32,191
+5% +$3.74M
NVDA icon
69
NVIDIA
NVDA
$4.74T
$81.4M 0.33%
13,840,720
-586,760
-4% -$3.05M
ILMN icon
70
Illumina
ILMN
$29.6B
$81.1M 0.33%
251,176
-32,939
-12% -$9.98M
MCHP icon
71
Microchip Technology
MCHP
$40.6B
$80.5M 0.33%
1,537,134
-265,306
-15% -$12.8M
ANSS
72
DELISTED
Ansys
ANSS
$79.9M 0.32%
310,244
-61,923
-17% -$14.6M
SPGI icon
73
S&P Global
SPGI
$125B
$79.8M 0.32%
292,394
-66,756
-19% -$17.3M
CVX icon
74
Chevron
CVX
$381B
$79.8M 0.32%
661,816
+39,182
+6% +$4.62M
EL icon
75
Estee Lauder
EL
$30.9B
$79.3M 0.32%
384,131
+84,401
+28% +$16.4M

Similar funds

Axa's Q4 2019 Portfolio in Review

As of Q4 2019, Axa held 1,387 positions worth $24.6B, down 2.1% from $25.1B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Axa withdrew a net $2.74B in Q4 2019, closing 225 positions and reducing 465 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Baker Hughes worth $26.1M.

  • Axa's largest Q4 2019 buy was Baker Hughes: 1,017,347 shares worth $26.1M.
  • Axa added most to Pfizer in Q4 2019, an estimated $66.4M increase.
  • Axa's biggest Q4 2019 reduction was iShares Core S&P 500 ETF, cutting an estimated $89.1M.
  • Axa fully exited iShares Russell 1000 Growth ETF in Q4 2019, selling an estimated $160M.
  • Axa's ten largest holdings make up 17% of its $24.6B portfolio in Q4 2019.
  • Axa opened 97 new positions and closed 225 in Q4 2019.
  • Axa's portfolio value fell 2.1% quarter-over-quarter to $24.6B.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.